List of articles with "cancer therapy"

IDEAYA's FDA Clearance

IDEAYA's FDA Clearance

United States cancer therapy ADC South San Francisco IDE034
Light-Pump Cancer Therapy

Light-Pump Cancer Therapy

Japan cancer therapy Okayama Okayama University Light-Pump
Compugen at Stifel 2025

Compugen at Stifel 2025

New York City Israel cancer therapy Compugen AI Drug Discovery
HCB101 Phase 1 Results

HCB101 Phase 1 Results

China Shanghai cancer therapy HanchorBio HCB101
ACM Biolabs Safety Updates

ACM Biolabs Safety Updates

Singapore cancer therapy ACM Biolabs ACM-CpG
Promising ACM-CpG Findings

Promising ACM-CpG Findings

Singapore cancer therapy ACM Biolabs ACM-CpG
Biond Biologics Study

Biond Biologics Study

Israel cancer therapy Biond Biologics BND-22 Misgav
Nuvalent at UBS 2025

Nuvalent at UBS 2025

United States Cambridge cancer therapy oncology Nuvalent
Cancer Treatment Alliance

Cancer Treatment Alliance

USA cancer therapy San Francisco Boehringer Ingelheim TegMine
Jacobio Pharma Growth

Jacobio Pharma Growth

China Beijing cancer therapy Jacobio Pharma glecirasib
Strong Q2 2025 Update

Strong Q2 2025 Update

United States cancer therapy Intensity Therapeutics Shelton INT230-6
ARTBIO Funding Success

ARTBIO Funding Success

USA Cambridge cancer therapy ARTBIO Alpha Radioligand
ARTBIO Raises $132M

ARTBIO Raises $132M

USA Cambridge cancer therapy ARTBIO Alpha Radioligand
SNB-101 Therapy Gains Support

SNB-101 Therapy Gains Support

South Korea cancer therapy Seongnam SN BioScience SNB-101
Phase 1 Trials Begin

Phase 1 Trials Begin

Canada cancer therapy Montreal Ipsen IRIC
Innovative Cancer Therapy Insights

Innovative Cancer Therapy Insights

USA cancer therapy Boston HotSpot Therapeutics CBM signalosome
Advanced Cancer Treatment

Advanced Cancer Treatment

cancer therapy Okayama Okayama University Nanocarbon Technology
Hoth Therapeutics KOL Event

Hoth Therapeutics KOL Event

USA New York cancer therapy Hoth Therapeutics HT-001
Hoth's HT-KIT Data

Hoth's HT-KIT Data

United States New York cancer therapy Hoth Therapeutics HT-KIT
Intensity's Public Offering

Intensity's Public Offering

cancer therapy Public Offering Intensity Therapeutics Shelton
Dendritic Cell Innovations

Dendritic Cell Innovations

USA cancer therapy Bethesda, Maryland Northwest Biotherapeutics DCVax
GNTbm's ASCO Presentation

GNTbm's ASCO Presentation

Taiwan Taipei cancer therapy GNTbm-38 Epigenetic Drug
Compugen Updates

Compugen Updates

Israel cancer therapy Compugen Holon COM701
BioVaxys-Sona Collaboration

BioVaxys-Sona Collaboration

None cancer therapy BioVaxys Sona Vancouver, Halifax
Immorta Bio at AAI 2025

Immorta Bio at AAI 2025

USA Miami cancer therapy Immorta Bio SenoVax
Privo Technologies CLN-004

Privo Technologies CLN-004

United States cancer therapy Various Privo Technologies CLN-004
Oramed and Alpha Tau Deal

Oramed and Alpha Tau Deal

United States New York cancer therapy Oramed Pharmaceuticals Alpha Tau Medical
Hoth's New Cancer Therapy Patent

Hoth's New Cancer Therapy Patent

Japan cancer therapy Tokyo Hoth Therapeutics KIT gene
Boron Neutron Trial

Boron Neutron Trial

Japan cancer therapy Tokyo Boron Neutron Sumitomo Heavy
ZEISS INTRABEAM 700

ZEISS INTRABEAM 700

Germany cancer therapy Jena ZEISS Medical Technology INTRABEAM 700
ArtemiCafe Trials Update

ArtemiCafe Trials Update

USA cancer therapy Clinical Trial Camp Hill ArtemiCafe
Future of Molecular Glues

Future of Molecular Glues

None cancer therapy DelveInsight Molecular Glues
Vivace Raises $35M

Vivace Raises $35M

United States cancer therapy San Mateo, California Vivace Therapeutics VT3989
Oncolytics Biotech Report

Oncolytics Biotech Report

Canada cancer therapy Calgary Oncolytics Biotech pelareorep
CStone Doses First Patient

CStone Doses First Patient

China Suzhou cancer therapy CStone Pharmaceuticals CS2009
Nuvalent at Investor Events

Nuvalent at Investor Events

United States Cambridge cancer therapy Nuvalent NUVL
CEO to Address Cancer Forum

CEO to Address Cancer Forum

cancer therapy United Kingdom Edinburgh TC BioPharm Bryan Kobel
Hirschfeld's Hope

Hirschfeld's Hope

USA cancer therapy oncology Brooklyn Azriel Hirschfeld
BioRay's BR111 Approval

BioRay's BR111 Approval

China Shanghai cancer therapy BioRay BR111
Ymmunobio's New Cancer Therapy

Ymmunobio's New Cancer Therapy

United States cancer therapy Princeton Ymmunobio YB-800
Vascarta's Chemotherapy Breakthrough

Vascarta's Chemotherapy Breakthrough

USA cancer therapy Vascarta CUNY Summit, New Jersey
Francis Medical Funding

Francis Medical Funding

United States cancer therapy Minneapolis Francis Medical Vanquish
Avenzo and DualityBio Partnership

Avenzo and DualityBio Partnership

USA San Diego cancer therapy Avenzo Therapeutics DualityBio
NUS Enhances Chemotherapy

NUS Enhances Chemotherapy

Singapore cancer therapy NUS Doxorubicin
Ottimo Pharma Funding

Ottimo Pharma Funding

London cancer therapy United Kingdom Ottimo Pharma Jankistomig
EO-3021 at ESMO 2024

EO-3021 at ESMO 2024

United States cancer therapy Boston Elevation Oncology EO-3021
New Cancer Treatment Approved

New Cancer Treatment Approved

China Suzhou cancer therapy TYVYT® ELUNATE®
Adcentrx Begins Phase 1b Trial

Adcentrx Begins Phase 1b Trial

United States San Diego cancer therapy Adcentrx ADRX-0706
Compugen's New Patent

Compugen's New Patent

Israel cancer therapy Compugen COM902 Holon
Anixa Acquires Bitcoin

Anixa Acquires Bitcoin

United States Anixa Biosciences Bitcoin cancer therapy San Jose

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.